APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pneumonia Treatment Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pneumonia Treatment Drugs Market Analysis and Forecast 2026-2032

22 December 2025198 pages

Choose your research edition.

Industry ResearchPneumonia Treatment Drugs Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Pneumonia Treatment Drugs Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Pneumonia Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pneumonia Treatment Drugs Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Pneumonia Treatment Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Pneumonia Treatment Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pneumonia Treatment Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pneumonia Treatment Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pneumonia Treatment Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pneumonia Treatment Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pneumonia Treatment Drugs include Teva Pharmaceutical, Sun Pharmaceutical, Novartis, Mylan, Pfizer, GlaxoSmithKline, AstraZeneca, Theravance Biopharma and Shinogi, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pneumonia Treatment Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pneumonia Treatment Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Pneumonia Treatment Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pneumonia Treatment Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pneumonia Treatment Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pneumonia Treatment Drugs sales, projected growth trends, production technology, application and end-user industry.

Pneumonia Treatment Drugs Segment by Company

Teva Pharmaceutical

Sun Pharmaceutical

Novartis

Mylan

Pfizer

GlaxoSmithKline

AstraZeneca

Theravance Biopharma

Shinogi

MSD

Medicines

Combioxin

Arsanis

Pneumonia Treatment Drugs Segment by Type

Vaccines

Vancomycin

Cephalosporin

Tetracyclines

Penicillin

Other Antibiotics

Immunotherapy Drug

Interferon

Fluoroquinolones

Macrolides

Pneumonia Treatment Drugs Segment by Application

Hospital

Clinic

Drugstore

Pneumonia Treatment Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pneumonia Treatment Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pneumonia Treatment Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pneumonia Treatment Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pneumonia Treatment Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pneumonia Treatment Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pneumonia Treatment Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pneumonia Treatment Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Vaccines Major Manufacturers Table 3. Vancomycin Major Manufacturers Table 4. Cephalosporin Major Manufacturers Table 5. Tetracyclines Major Manufacturers Table 6. Penicillin Major Manufacturers Table 7. Other Antibiotics Major Manufacturers Table 8. Immunotherapy Drug Major Manufacturers Table 9. Interferon Major Manufacturers Table 10. Fluoroquinolones Major Manufacturers Table 11. Macrolides Major Manufacturers Table 12. Global Pneumonia Treatment Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 13. Hospital Major Manufacturers Table 14. Clinic Major Manufacturers Table 15. Drugstore Major Manufacturers Table 16. Pneumonia Treatment Drugs Industry Trends Table 17. Pneumonia Treatment Drugs Industry Drivers Table 18. Pneumonia Treatment Drugs Industry Opportunities and Challenges Table 19. Pneumonia Treatment Drugs Industry Restraints Table 20. Global Pneumonia Treatment Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Pneumonia Treatment Drugs Revenue by Region (2021-2026) & (US$ Million) Table 22. Global Pneumonia Treatment Drugs Revenue by Region (2027-2032) & (US$ Million) Table 23. Global Pneumonia Treatment Drugs Revenue Market Share by Region (2021-2026) Table 24. Global Pneumonia Treatment Drugs Revenue Market Share by Region (2027-2032) Table 25. Global Pneumonia Treatment Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 26. Global Pneumonia Treatment Drugs Sales by Region (2021-2026) & (k units) Table 27. Global Pneumonia Treatment Drugs Sales by Region (2027-2032) & (k units) Table 28. Global Pneumonia Treatment Drugs Sales Market Share by Region (2021-2026) Table 29. Global Pneumonia Treatment Drugs Sales Market Share by Region (2027-2032) Table 30. Global Pneumonia Treatment Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 31. Global Pneumonia Treatment Drugs Revenue Market Share by Manufacturers (2021-2026) Table 32. Global Pneumonia Treatment Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 33. Global Pneumonia Treatment Drugs Sales Market Share by Manufacturers (2021-2026) Table 34. Global Pneumonia Treatment Drugs Sales Price (US$/unit) of Manufacturers (2021-2026) Table 35. Global Pneumonia Treatment Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 36. Global Pneumonia Treatment Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 37. Global Pneumonia Treatment Drugs Manufacturers, Product Type & Application Table 38. Global Pneumonia Treatment Drugs Manufacturers' Establishment Date Table 39. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 40. Global Pneumonia Treatment Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Pneumonia Treatment Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Pneumonia Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 43. Global Pneumonia Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 44. Global Pneumonia Treatment Drugs Revenue Market Share by Type (2021-2026) Table 45. Global Pneumonia Treatment Drugs Revenue Market Share by Type (2027-2032) Table 46. Global Pneumonia Treatment Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 47. Global Pneumonia Treatment Drugs Sales by Type (2021-2026) & (k units) Table 48. Global Pneumonia Treatment Drugs Sales by Type (2027-2032) & (k units) Table 49. Global Pneumonia Treatment Drugs Sales Market Share by Type (2021-2026) Table 50. Global Pneumonia Treatment Drugs Sales Market Share by Type (2027-2032) Table 51. Global Pneumonia Treatment Drugs Price by Type (2021-2026) & (US$/unit) Table 52. Global Pneumonia Treatment Drugs Price by Type (2027-2032) & (US$/unit) Table 53. Global Pneumonia Treatment Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 54. Global Pneumonia Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 55. Global Pneumonia Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 56. Global Pneumonia Treatment Drugs Revenue Market Share by Application (2021-2026) Table 57. Global Pneumonia Treatment Drugs Revenue Market Share by Application (2027-2032) Table 58. Global Pneumonia Treatment Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 59. Global Pneumonia Treatment Drugs Sales by Application (2021-2026) & (k units) Table 60. Global Pneumonia Treatment Drugs Sales by Application (2027-2032) & (k units) Table 61. Global Pneumonia Treatment Drugs Sales Market Share by Application (2021-2026) Table 62. Global Pneumonia Treatment Drugs Sales Market Share by Application (2027-2032) Table 63. Global Pneumonia Treatment Drugs Price by Application (2021-2026) & (US$/unit) Table 64. Global Pneumonia Treatment Drugs Price by Application (2027-2032) & (US$/unit) Table 65. Teva Pharmaceutical Company Information Table 66. Teva Pharmaceutical Business Overview Table 67. Teva Pharmaceutical Pneumonia Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Teva Pharmaceutical Pneumonia Treatment Drugs Product Portfolio Table 69. Teva Pharmaceutical Recent Development Table 70. Sun Pharmaceutical Company Information Table 71. Sun Pharmaceutical Business Overview Table 72. Sun Pharmaceutical Pneumonia Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Sun Pharmaceutical Pneumonia Treatment Drugs Product Portfolio Table 74. Sun Pharmaceutical Recent Development Table 75. Novartis Company Information Table 76. Novartis Business Overview Table 77. Novartis Pneumonia Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Novartis Pneumonia Treatment Drugs Product Portfolio Table 79. Novartis Recent Development Table 80. Mylan Company Information Table 81. Mylan Business Overview Table 82. Mylan Pneumonia Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Mylan Pneumonia Treatment Drugs Product Portfolio Table 84. Mylan Recent Development Table 85. Pfizer Company Information Table 86. Pfizer Business Overview Table 87. Pfizer Pneumonia Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Pfizer Pneumonia Treatment Drugs Product Portfolio Table 89. Pfizer Recent Development Table 90. GlaxoSmithKline Company Information Table 91. GlaxoSmithKline Business Overview Table 92. GlaxoSmithKline Pneumonia Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. GlaxoSmithKline Pneumonia Treatment Drugs Product Portfolio Table 94. GlaxoSmithKline Recent Development Table 95. AstraZeneca Company Information Table 96. AstraZeneca Business Overview Table 97. AstraZeneca Pneumonia Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. AstraZeneca Pneumonia Treatment Drugs Product Portfolio Table 99. AstraZeneca Recent Development Table 100. Theravance Biopharma Company Information Table 101. Theravance Biopharma Business Overview Table 102. Theravance Biopharma Pneumonia Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Theravance Biopharma Pneumonia Treatment Drugs Product Portfolio Table 104. Theravance Biopharma Recent Development Table 105. Shinogi Company Information Table 106. Shinogi Business Overview Table 107. Shinogi Pneumonia Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. Shinogi Pneumonia Treatment Drugs Product Portfolio Table 109. Shinogi Recent Development Table 110. MSD Company Information Table 111. MSD Business Overview Table 112. MSD Pneumonia Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. MSD Pneumonia Treatment Drugs Product Portfolio Table 114. MSD Recent Development Table 115. Medicines Company Information Table 116. Medicines Business Overview Table 117. Medicines Pneumonia Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. Medicines Pneumonia Treatment Drugs Product Portfolio Table 119. Medicines Recent Development Table 120. Combioxin Company Information Table 121. Combioxin Business Overview Table 122. Combioxin Pneumonia Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 123. Combioxin Pneumonia Treatment Drugs Product Portfolio Table 124. Combioxin Recent Development Table 125. Arsanis Company Information Table 126. Arsanis Business Overview Table 127. Arsanis Pneumonia Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 128. Arsanis Pneumonia Treatment Drugs Product Portfolio Table 129. Arsanis Recent Development Table 130. North America Pneumonia Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 131. North America Pneumonia Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 132. North America Pneumonia Treatment Drugs Sales by Type (2021-2026) & (k units) Table 133. North America Pneumonia Treatment Drugs Sales by Type (2027-2032) & (k units) Table 134. North America Pneumonia Treatment Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 135. North America Pneumonia Treatment Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 136. North America Pneumonia Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 137. North America Pneumonia Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 138. North America Pneumonia Treatment Drugs Sales by Application (2021-2026) & (k units) Table 139. North America Pneumonia Treatment Drugs Sales by Application (2027-2032) & (k units) Table 140. North America Pneumonia Treatment Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 141. North America Pneumonia Treatment Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 142. North America Pneumonia Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. North America Pneumonia Treatment Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 144. North America Pneumonia Treatment Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 145. North America Pneumonia Treatment Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 146. North America Pneumonia Treatment Drugs Sales by Country (2021-2026) & (k units) Table 147. North America Pneumonia Treatment Drugs Sales by Country (2027-2032) & (k units) Table 148. North America Pneumonia Treatment Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 149. North America Pneumonia Treatment Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 150. United States Pneumonia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 151. Canada Pneumonia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 152. Mexico Pneumonia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 153. Europe Pneumonia Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 154. Europe Pneumonia Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 155. Europe Pneumonia Treatment Drugs Sales by Type (2021-2026) & (k units) Table 156. Europe Pneumonia Treatment Drugs Sales by Type (2027-2032) & (k units) Table 157. Europe Pneumonia Treatment Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 158. Europe Pneumonia Treatment Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 159. Europe Pneumonia Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 160. Europe Pneumonia Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 161. Europe Pneumonia Treatment Drugs Sales by Application (2021-2026) & (k units) Table 162. Europe Pneumonia Treatment Drugs Sales by Application (2027-2032) & (k units) Table 163. Europe Pneumonia Treatment Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 164. Europe Pneumonia Treatment Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 165. Europe Pneumonia Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. Europe Pneumonia Treatment Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 167. Europe Pneumonia Treatment Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 168. Europe Pneumonia Treatment Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 169. Europe Pneumonia Treatment Drugs Sales by Country (2021-2026) & (k units) Table 170. Europe Pneumonia Treatment Drugs Sales by Country (2027-2032) & (k units) Table 171. Europe Pneumonia Treatment Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 172. Europe Pneumonia Treatment Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 173. Germany Pneumonia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 174. France Pneumonia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 175. U.K. Pneumonia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 176. Italy Pneumonia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 177. Russia Pneumonia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 178. Spain Pneumonia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 179. Netherlands Pneumonia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 180. Switzerland Pneumonia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 181. Sweden Pneumonia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 182. Poland Pneumonia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 183. China Pneumonia Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 184. China Pneumonia Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 185. China Pneumonia Treatment Drugs Sales by Type (2021-2026) & (k units) Table 186. China Pneumonia Treatment Drugs Sales by Type (2027-2032) & (k units) Table 187. China Pneumonia Treatment Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 188. China Pneumonia Treatment Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 189. China Pneumonia Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 190. China Pneumonia Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 191. China Pneumonia Treatment Drugs Sales by Application (2021-2026) & (k units) Table 192. China Pneumonia Treatment Drugs Sales by Application (2027-2032) & (k units) Table 193. China Pneumonia Treatment Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 194. China Pneumonia Treatment Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 195. Asia Pneumonia Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 196. Asia Pneumonia Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 197. Asia Pneumonia Treatment Drugs Sales by Type (2021-2026) & (k units) Table 198. Asia Pneumonia Treatment Drugs Sales by Type (2027-2032) & (k units) Table 199. Asia Pneumonia Treatment Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 200. Asia Pneumonia Treatment Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 201. Asia Pneumonia Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 202. Asia Pneumonia Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 203. Asia Pneumonia Treatment Drugs Sales by Application (2021-2026) & (k units) Table 204. Asia Pneumonia Treatment Drugs Sales by Application (2027-2032) & (k units) Table 205. Asia Pneumonia Treatment Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 206. Asia Pneumonia Treatment Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 207. Asia Pneumonia Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 208. Asia Pneumonia Treatment Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 209. Asia Pneumonia Treatment Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 210. Asia Pneumonia Treatment Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 211. Asia Pneumonia Treatment Drugs Sales by Country (2021-2026) & (k units) Table 212. Asia Pneumonia Treatment Drugs Sales by Country (2027-2032) & (k units) Table 213. Asia Pneumonia Treatment Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 214. Asia Pneumonia Treatment Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 215. Japan Pneumonia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 216. South Korea Pneumonia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 217. India Pneumonia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 218. Australia Pneumonia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 219. Taiwan Pneumonia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 220. Southeast Asia Pneumonia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 221. SAMEA Pneumonia Treatment Drugs Revenue by Type (2021-2026) & (US$ Million) Table 222. SAMEA Pneumonia Treatment Drugs Revenue by Type (2027-2032) & (US$ Million) Table 223. SAMEA Pneumonia Treatment Drugs Sales by Type (2021-2026) & (k units) Table 224. SAMEA Pneumonia Treatment Drugs Sales by Type (2027-2032) & (k units) Table 225. SAMEA Pneumonia Treatment Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 226. SAMEA Pneumonia Treatment Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 227. SAMEA Pneumonia Treatment Drugs Revenue by Application (2021-2026) & (US$ Million) Table 228. SAMEA Pneumonia Treatment Drugs Revenue by Application (2027-2032) & (US$ Million) Table 229. SAMEA Pneumonia Treatment Drugs Sales by Application (2021-2026) & (k units) Table 230. SAMEA Pneumonia Treatment Drugs Sales by Application (2027-2032) & (k units) Table 231. SAMEA Pneumonia Treatment Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 232. SAMEA Pneumonia Treatment Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 233. SAMEA Pneumonia Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 234. SAMEA Pneumonia Treatment Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 235. SAMEA Pneumonia Treatment Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 236. SAMEA Pneumonia Treatment Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 237. SAMEA Pneumonia Treatment Drugs Sales by Country (2021-2026) & (k units) Table 238. SAMEA Pneumonia Treatment Drugs Sales by Country (2027-2032) & (k units) Table 239. SAMEA Pneumonia Treatment Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 240. SAMEA Pneumonia Treatment Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 241. Brazil Pneumonia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 242. Argentina Pneumonia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 243. Chile Pneumonia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 244. Colombia Pneumonia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 245. Peru Pneumonia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 246. Saudi Arabia Pneumonia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 247. Israel Pneumonia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 248. UAE Pneumonia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 249. Turkey Pneumonia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 250. Iran Pneumonia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 251. Egypt Pneumonia Treatment Drugs Revenue (2021-2032) & (US$ Million) Table 252. Key Raw Materials Table 253. Raw Materials Key Suppliers Table 254. Pneumonia Treatment Drugs Distributors List Table 255. Pneumonia Treatment Drugs Customers List Table 256. Research Programs/Design for This Report Table 257. Authors List of This Report Table 258. Secondary Sources Table 259. Primary Sources List of Figures Figure 1. Pneumonia Treatment Drugs Image Figure 2. Global Pneumonia Treatment Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pneumonia Treatment Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Vaccines Image Figure 5. Vancomycin Image Figure 6. Cephalosporin Image Figure 7. Tetracyclines Image Figure 8. Penicillin Image Figure 9. Other Antibiotics Image Figure 10. Immunotherapy Drug Image Figure 11. Interferon Image Figure 12. Fluoroquinolones Image Figure 13. Macrolides Image Figure 14. Global Pneumonia Treatment Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Pneumonia Treatment Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Drugstore Image Figure 19. Global Pneumonia Treatment Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 20. Global Pneumonia Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 21. Global Pneumonia Treatment Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Pneumonia Treatment Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 23. Global Pneumonia Treatment Drugs Revenue Market Share by Region (2021-2032) Figure 24. Global Pneumonia Treatment Drugs Sales (2021-2032) & (k units) Figure 25. Global Pneumonia Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global Pneumonia Treatment Drugs Sales Market Share by Region (2021-2032) Figure 27. US & Canada & Mexico Pneumonia Treatment Drugs Sales YoY (2021-2032) & (k units) Figure 28. Europe Pneumonia Treatment Drugs Sales YoY (2021-2032) & (k units) Figure 29. China Pneumonia Treatment Drugs Sales YoY (2021-2032) & (k units) Figure 30. Asia (Excluding China) Pneumonia Treatment Drugs Sales YoY (2021-2032) & (k units) Figure 31. South America, Middle East and Africa Pneumonia Treatment Drugs Sales YoY (2021-2032) & (k units) Figure 32. Global Pneumonia Treatment Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 33. Global Pneumonia Treatment Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 34. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 35. Global Pneumonia Treatment Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Pneumonia Treatment Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Pneumonia Treatment Drugs Revenue Market Share by Type (2021-2032) Figure 38. Global Pneumonia Treatment Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 39. Global Pneumonia Treatment Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 40. Global Pneumonia Treatment Drugs Sales Market Share by Type (2021-2032) Figure 41. Global Pneumonia Treatment Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 42. Global Pneumonia Treatment Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Pneumonia Treatment Drugs Revenue Market Share by Application (2021-2032) Figure 44. Global Pneumonia Treatment Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 45. Global Pneumonia Treatment Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 46. Global Pneumonia Treatment Drugs Sales Market Share by Application (2021-2032) Figure 47. North America Pneumonia Treatment Drugs Revenue Share by Type (2021-2032) Figure 48. North America Pneumonia Treatment Drugs Sales Share by Type (2021-2032) Figure 49. North America Pneumonia Treatment Drugs Revenue Share by Application (2021-2032) Figure 50. North America Pneumonia Treatment Drugs Sales Share by Application (2021-2032) Figure 51. North America Pneumonia Treatment Drugs Revenue Share by Country (2021-2032) Figure 52. North America Pneumonia Treatment Drugs Sales Share by Country (2021-2032) Figure 53. Europe Pneumonia Treatment Drugs Revenue Share by Type (2021-2032) Figure 54. Europe Pneumonia Treatment Drugs Sales Share by Type (2021-2032) Figure 55. Europe Pneumonia Treatment Drugs Revenue Share by Application (2021-2032) Figure 56. Europe Pneumonia Treatment Drugs Sales Share by Application (2021-2032) Figure 57. Europe Pneumonia Treatment Drugs Revenue Share by Country (2021-2032) Figure 58. Europe Pneumonia Treatment Drugs Sales Share by Country (2021-2032) Figure 59. China Pneumonia Treatment Drugs Revenue Share by Type (2021-2032) Figure 60. China Pneumonia Treatment Drugs Sales Share by Type (2021-2032) Figure 61. China Pneumonia Treatment Drugs Revenue Share by Application (2021-2032) Figure 62. China Pneumonia Treatment Drugs Sales Share by Application (2021-2032) Figure 63. Asia Pneumonia Treatment Drugs Revenue Share by Type (2021-2032) Figure 64. Asia Pneumonia Treatment Drugs Sales Share by Type (2021-2032) Figure 65. Asia Pneumonia Treatment Drugs Revenue Share by Application (2021-2032) Figure 66. Asia Pneumonia Treatment Drugs Sales Share by Application (2021-2032) Figure 67. Asia Pneumonia Treatment Drugs Revenue Share by Country (2021-2032) Figure 68. Asia Pneumonia Treatment Drugs Sales Share by Country (2021-2032) Figure 69. SAMEA Pneumonia Treatment Drugs Revenue Share by Type (2021-2032) Figure 70. SAMEA Pneumonia Treatment Drugs Sales Share by Type (2021-2032) Figure 71. SAMEA Pneumonia Treatment Drugs Revenue Share by Application (2021-2032) Figure 72. SAMEA Pneumonia Treatment Drugs Sales Share by Application (2021-2032) Figure 73. SAMEA Pneumonia Treatment Drugs Revenue Share by Country (2021-2032) Figure 74. SAMEA Pneumonia Treatment Drugs Sales Share by Country (2021-2032) Figure 75. Pneumonia Treatment Drugs Value Chain Figure 76. Manufacturing Cost Structure Figure 77. Pneumonia Treatment Drugs Production Mode & Process Figure 78. Direct Comparison with Distribution Share Figure 79. Distributors Profiles Figure 80. Years Considered Figure 81. Research Process Figure 82. Key Executives Interviewed

Scope & coverage.

Types
  • Vaccines
  • Vancomycin
  • Cephalosporin
  • Tetracyclines
  • Penicillin
  • Other Antibiotics
  • Immunotherapy Drug
  • Interferon
  • Fluoroquinolones
  • Macrolides
Applications
  • Hospital
  • Clinic
  • Drugstore
Companies covered
  • Teva Pharmaceutical
  • Sun Pharmaceutical
  • Novartis
  • Mylan
  • Pfizer
  • GlaxoSmithKline
  • AstraZeneca
  • Theravance Biopharma
  • Shinogi
  • MSD
  • Medicines
  • Combioxin
  • Arsanis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pneumonia Treatment Drugs Market by Type
  3. 1.2.1 Global Pneumonia Treatment Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Vaccines
  5. 1.2.3 Vancomycin
  6. 1.2.4 Cephalosporin
  7. 1.2.5 Tetracyclines
  8. 1.2.6 Penicillin
  9. 1.2.7 Other Antibiotics
  10. 1.2.8 Immunotherapy Drug
  11. 1.2.9 Interferon
  12. 1.2.10 Fluoroquinolones
  13. 1.2.11 Macrolides
  14. 1.3 Pneumonia Treatment Drugs Market by Application
  15. 1.3.1 Global Pneumonia Treatment Drugs Market Size by Application, 2021 VS 2025 VS 2032
  16. 1.3.2 Hospital
  17. 1.3.3 Clinic
  18. 1.3.4 Drugstore
  19. 1.4 Assumptions and Limitations
  20. 1.5 Study Goals and Objectives
2 Pneumonia Treatment Drugs Market Dynamics
  1. 2.1 Pneumonia Treatment Drugs Industry Trends
  2. 2.2 Pneumonia Treatment Drugs Industry Drivers
  3. 2.3 Pneumonia Treatment Drugs Industry Opportunities and Challenges
  4. 2.4 Pneumonia Treatment Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pneumonia Treatment Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pneumonia Treatment Drugs Revenue by Region
  3. 3.2.1 Global Pneumonia Treatment Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pneumonia Treatment Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Pneumonia Treatment Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Pneumonia Treatment Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pneumonia Treatment Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pneumonia Treatment Drugs Sales by Region
  9. 3.4.1 Global Pneumonia Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pneumonia Treatment Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Pneumonia Treatment Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Pneumonia Treatment Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pneumonia Treatment Drugs Revenue by Manufacturers
  2. 4.1.1 Global Pneumonia Treatment Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pneumonia Treatment Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pneumonia Treatment Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pneumonia Treatment Drugs Sales by Manufacturers
  6. 4.2.1 Global Pneumonia Treatment Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pneumonia Treatment Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pneumonia Treatment Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pneumonia Treatment Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pneumonia Treatment Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pneumonia Treatment Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pneumonia Treatment Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Pneumonia Treatment Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pneumonia Treatment Drugs Market CR5 and HHI
  16. 4.8.2 2025 Pneumonia Treatment Drugs Tier 1, Tier 2, and Tier 3
5 Pneumonia Treatment Drugs Market by Type
  1. 5.1 Global Pneumonia Treatment Drugs Revenue by Type
  2. 5.1.1 Global Pneumonia Treatment Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pneumonia Treatment Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pneumonia Treatment Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pneumonia Treatment Drugs Sales by Type
  6. 5.2.1 Global Pneumonia Treatment Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pneumonia Treatment Drugs Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Pneumonia Treatment Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pneumonia Treatment Drugs Price by Type
6 Pneumonia Treatment Drugs Market by Application
  1. 6.1 Global Pneumonia Treatment Drugs Revenue by Application
  2. 6.1.1 Global Pneumonia Treatment Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pneumonia Treatment Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pneumonia Treatment Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pneumonia Treatment Drugs Sales by Application
  6. 6.2.1 Global Pneumonia Treatment Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pneumonia Treatment Drugs Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Pneumonia Treatment Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pneumonia Treatment Drugs Price by Application
7 Company Profiles
  1. 7.1 Teva Pharmaceutical
  2. 7.1.1 Teva Pharmaceutical Company Information
  3. 7.1.2 Teva Pharmaceutical Business Overview
  4. 7.1.3 Teva Pharmaceutical Pneumonia Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Pharmaceutical Pneumonia Treatment Drugs Product Portfolio
  6. 7.1.5 Teva Pharmaceutical Recent Developments
  7. 7.2 Sun Pharmaceutical
  8. 7.2.1 Sun Pharmaceutical Company Information
  9. 7.2.2 Sun Pharmaceutical Business Overview
  10. 7.2.3 Sun Pharmaceutical Pneumonia Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sun Pharmaceutical Pneumonia Treatment Drugs Product Portfolio
  12. 7.2.5 Sun Pharmaceutical Recent Developments
  13. 7.3 Novartis
  14. 7.3.1 Novartis Company Information
  15. 7.3.2 Novartis Business Overview
  16. 7.3.3 Novartis Pneumonia Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Novartis Pneumonia Treatment Drugs Product Portfolio
  18. 7.3.5 Novartis Recent Developments
  19. 7.4 Mylan
  20. 7.4.1 Mylan Company Information
  21. 7.4.2 Mylan Business Overview
  22. 7.4.3 Mylan Pneumonia Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Mylan Pneumonia Treatment Drugs Product Portfolio
  24. 7.4.5 Mylan Recent Developments
  25. 7.5 Pfizer
  26. 7.5.1 Pfizer Company Information
  27. 7.5.2 Pfizer Business Overview
  28. 7.5.3 Pfizer Pneumonia Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Pfizer Pneumonia Treatment Drugs Product Portfolio
  30. 7.5.5 Pfizer Recent Developments
  31. 7.6 GlaxoSmithKline
  32. 7.6.1 GlaxoSmithKline Company Information
  33. 7.6.2 GlaxoSmithKline Business Overview
  34. 7.6.3 GlaxoSmithKline Pneumonia Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 GlaxoSmithKline Pneumonia Treatment Drugs Product Portfolio
  36. 7.6.5 GlaxoSmithKline Recent Developments
  37. 7.7 AstraZeneca
  38. 7.7.1 AstraZeneca Company Information
  39. 7.7.2 AstraZeneca Business Overview
  40. 7.7.3 AstraZeneca Pneumonia Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 AstraZeneca Pneumonia Treatment Drugs Product Portfolio
  42. 7.7.5 AstraZeneca Recent Developments
  43. 7.8 Theravance Biopharma
  44. 7.8.1 Theravance Biopharma Company Information
  45. 7.8.2 Theravance Biopharma Business Overview
  46. 7.8.3 Theravance Biopharma Pneumonia Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Theravance Biopharma Pneumonia Treatment Drugs Product Portfolio
  48. 7.8.5 Theravance Biopharma Recent Developments
  49. 7.9 Shinogi
  50. 7.9.1 Shinogi Company Information
  51. 7.9.2 Shinogi Business Overview
  52. 7.9.3 Shinogi Pneumonia Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Shinogi Pneumonia Treatment Drugs Product Portfolio
  54. 7.9.5 Shinogi Recent Developments
  55. 7.10 MSD
  56. 7.10.1 MSD Company Information
  57. 7.10.2 MSD Business Overview
  58. 7.10.3 MSD Pneumonia Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 MSD Pneumonia Treatment Drugs Product Portfolio
  60. 7.10.5 MSD Recent Developments
  61. 7.11 Medicines
  62. 7.11.1 Medicines Company Information
  63. 7.11.2 Medicines Business Overview
  64. 7.11.3 Medicines Pneumonia Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Medicines Pneumonia Treatment Drugs Product Portfolio
  66. 7.11.5 Medicines Recent Developments
  67. 7.12 Combioxin
  68. 7.12.1 Combioxin Company Information
  69. 7.12.2 Combioxin Business Overview
  70. 7.12.3 Combioxin Pneumonia Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Combioxin Pneumonia Treatment Drugs Product Portfolio
  72. 7.12.5 Combioxin Recent Developments
  73. 7.13 Arsanis
  74. 7.13.1 Arsanis Company Information
  75. 7.13.2 Arsanis Business Overview
  76. 7.13.3 Arsanis Pneumonia Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Arsanis Pneumonia Treatment Drugs Product Portfolio
  78. 7.13.5 Arsanis Recent Developments
8 North America
  1. 8.1 North America Pneumonia Treatment Drugs Market Size by Type
  2. 8.1.1 North America Pneumonia Treatment Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Pneumonia Treatment Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Pneumonia Treatment Drugs Price by Type (2021-2032)
  5. 8.2 North America Pneumonia Treatment Drugs Market Size by Application
  6. 8.2.1 North America Pneumonia Treatment Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Pneumonia Treatment Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Pneumonia Treatment Drugs Price by Application (2021-2032)
  9. 8.3 North America Pneumonia Treatment Drugs Market Size by Country
  10. 8.3.1 North America Pneumonia Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pneumonia Treatment Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pneumonia Treatment Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Pneumonia Treatment Drugs Market Size by Type
  2. 9.1.1 Europe Pneumonia Treatment Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pneumonia Treatment Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Pneumonia Treatment Drugs Price by Type (2021-2032)
  5. 9.2 Europe Pneumonia Treatment Drugs Market Size by Application
  6. 9.2.1 Europe Pneumonia Treatment Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pneumonia Treatment Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Pneumonia Treatment Drugs Price by Application (2021-2032)
  9. 9.3 Europe Pneumonia Treatment Drugs Market Size by Country
  10. 9.3.1 Europe Pneumonia Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pneumonia Treatment Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pneumonia Treatment Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Pneumonia Treatment Drugs Market Size by Type
  2. 10.1.1 China Pneumonia Treatment Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Pneumonia Treatment Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Pneumonia Treatment Drugs Price by Type (2021-2032)
  5. 10.2 China Pneumonia Treatment Drugs Market Size by Application
  6. 10.2.1 China Pneumonia Treatment Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Pneumonia Treatment Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Pneumonia Treatment Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pneumonia Treatment Drugs Market Size by Type
  2. 11.1.1 Asia Pneumonia Treatment Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pneumonia Treatment Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Pneumonia Treatment Drugs Price by Type (2021-2032)
  5. 11.2 Asia Pneumonia Treatment Drugs Market Size by Application
  6. 11.2.1 Asia Pneumonia Treatment Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pneumonia Treatment Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Pneumonia Treatment Drugs Price by Application (2021-2032)
  9. 11.3 Asia Pneumonia Treatment Drugs Market Size by Country
  10. 11.3.1 Asia Pneumonia Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pneumonia Treatment Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pneumonia Treatment Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pneumonia Treatment Drugs Market Size by Type
  2. 12.1.1 SAMEA Pneumonia Treatment Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pneumonia Treatment Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pneumonia Treatment Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Pneumonia Treatment Drugs Market Size by Application
  6. 12.2.1 SAMEA Pneumonia Treatment Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pneumonia Treatment Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pneumonia Treatment Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Pneumonia Treatment Drugs Market Size by Country
  10. 12.3.1 SAMEA Pneumonia Treatment Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pneumonia Treatment Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pneumonia Treatment Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pneumonia Treatment Drugs Value Chain Analysis
  2. 13.1.1 Pneumonia Treatment Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pneumonia Treatment Drugs Production Mode & Process
  6. 13.2 Pneumonia Treatment Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pneumonia Treatment Drugs Distributors
  9. 13.2.3 Pneumonia Treatment Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst